Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
Search by expertise, name or affiliation
Levonorgestrel intrauterine system versus medical therapy for menorrhagia
School of Psychology
Aston Research Centre for Health in Ageing
College of Health and Life Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Levonorgestrel intrauterine system versus medical therapy for menorrhagia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Menorrhagia
100%
Levonorgestrel-releasing Intrauterine System (LNG-IUS)
100%
Medical Therapy
100%
Attribute Scale
41%
Multi-attribute
41%
Medical Treatment
33%
Treatment as Usual
25%
Sexual Behavior
16%
Social Life
16%
Between-group Difference
16%
Surgical Intervention
16%
Activity Score
16%
Primary Care Setting
16%
Mean Group
8%
Confidence Interval
8%
United States
8%
Physical Health
8%
Mefenamic Acid
8%
Psychological Health
8%
Treatment Group
8%
Quality of Life Improvement
8%
Abnormal Uterine Bleeding
8%
Progesterone
8%
2-year Follow-up
8%
Healthcare Workers
8%
Treatment Options
8%
Emotional Life
8%
Bleeding
8%
Condition-dependent
8%
Family Life
8%
Family Relationships
8%
Updated Meta-analysis
8%
Work Routines
8%
Serious Adverse Events
8%
Scale Domain
8%
Multicenter Randomized Trial
8%
Intervention Engagement
8%
Quality of Life Domains
8%
Tranexamic Acid
8%
Daily Routines
8%
Estrogen
8%
Non-hormonal Treatment
8%
General Health-related Quality of Life
8%
Progestogens
8%
Physical-life
8%
Short-term Benefits
8%
Related Quality of Life
8%
Testing Trends
8%
Hormonal Treatment
8%
Menstrual Blood Loss
8%
Nursing and Health Professions
Menorrhagia
100%
Combination Therapy
100%
Levonorgestrel
100%
Levonorgestrel Releasing Intrauterine System
100%
Quality of Life
36%
Primary Medical Care
18%
Social Life
18%
Surgery
18%
Mental Health
9%
Confidence Interval
9%
Meta Analysis
9%
Adverse Event
9%
Bleeding
9%
Mefenamic Acid
9%
Tranexamic Acid
9%
Progesterone
9%
Gestagen
9%
Treatment Group
9%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
100%
Levonorgestrel
100%
Menorrhagia
100%
Mefenamic Acid
8%
Adverse Event
8%
Progesterone
8%
Bleeding
8%
Tranexamic Acid
8%
Progestin
8%
Treatment Group
8%
Psychology
Quality of Life
100%
Social Participation
50%
Mental Health
25%
Meta-Analysis
25%
Life Domain
25%
Progesterone
25%
Neuroscience
Levonorgestrel
100%
Progesterone
8%
Meta-Analysis
8%
Tranexamic Acid
8%
Mefenamic Acid
8%
Progestin
8%